With 38 crore people infected India may have reached herd immunity

▴ With 38 crore people infected India may have reached herd immunity
The study strongly advocates the fact that a timely lockdown may have reduced the fatality of coronavirus cases in India

A study has claimed that India may have reached herd immunity with about 380 million or 38 crore people already infected.

The detailed study published in the Indian Journal of Medical Research (IJMR) claims to have used susceptible-asymptomatic-infected-recovered (SAIR) model to assess the impact of the lockdown and make predictions on its future course.

“The SAIR model has helped us understand the disease better. If the model is correct, we may have reached herd immunity with about 38 crore people already infected. However, personal protective measures remain crucial,” the authors Manindra Agrawal, Madhuri Kanitkar and M Vidyasagar were quoted in the study as saying.

The study strongly advocates the fact that a timely lockdown may have reduced the fatality of coronavirus cases in India. It also claims that without a lockdown intervention led by the Indian government in the month of March, Covid-19 infections would have peaked by June 2020.

“If there was no lockdown, the number of active infections would have peaked at close to 14.7 million (1.4 crores), resulted in more than 2.6 million (26 lakh) deaths, and the peak would have arrived by June 2020. The number of deaths with the current trends may be less than 0.2 million (2 lakhs),” notes the study.

Method and modelling:

The standard mathematical models could not explain the role of asymptomatic cases in the unfolding of the pandemic, the study noted. A new model was used which was developed on lines of SAIR.

“There is a paucity of data on the behaviour of the virus among the Indian population. Limited testing capability in India at the time of onset of the pandemic, non-availability of standardized tests for serosurveillance and non-availability of data on asymptomatic cases were other limitations. In the current Covid-19 pandemic, a large fraction of the population showed little or no symptoms,” said the study.

Four parameters were used, namely:

Measures the likelihood of the susceptible people getting infected, and denotes recovery rate of patients. The ratio is denoted by R0 (basic reproduction number).

Pandemic progression in India:

The actual data suggested a peak in coronavirus cases in India on September 17, 2020. The model overestimates the actual growth by around 1.5 per cent and the peak arrives four days later. Cumulative deaths are predicted to be around 0.2 million.

The and values for the last phase imply R0 value around 1.39, and the herd immunity for this value of R0 at around 28 per cent of the population in A, I and R categories.

According to the study, around 3.9 million (39 lakh) population was infected or with antibodies at the peak. On September 17, the numbers in I and RI categories were around 5.2 million (52 lakh). Using the 1/ value (=67) of phase 6, the model predicts the total population with infection or antibodies to be around 3.5 million (35 lakh).

Story Source: www.indiatoday.com 

Tags : #IndianJournalofMedicalResearch #HerdImmunity #COVIDAntibody #LatestCOVIDNews23rdOct #Lockdown #FatalityRate #COVID19Pandemic

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024